SUBSCRIBERS
Drugmaker Shire offers to buy Baxalta for US$30b
Published Wed, Aug 5, 2015 · 09:50 PM
London
IRISH drugmaker Shire said on Tuesday that it had offered to buy the biopharmaceutical company Baxalta in an all-stock deal worth about US$30 billion.
Shire said on Tuesday that it had approached Baxalta in early July about a potential combination, but Baxalta concluded, following a written proposal on July 31, not to proceed with discussions.
The takeover approach came shortly after Baxter International spun out its forme…
BT is now on Telegram!
For daily updates on weekdays and specially selected content for the weekend. Subscribe to t.me/BizTimes
Consumer & Healthcare
China bubble-tea chain Chabaidao plunges on Hong Kong debut
Japan’s 7-Eleven convenience chain targets aggressive global growth
Parental fury after stem cell bank ruins thousands of samples in Singapore
China’s bubble tea boom creates a half-dozen billionaires
US sues to block Coach owner’s US$8.5 billion buyout of Versace parent
Cutting the cord?: Events leading up to Cordlife’s MOH suspension and arrests of its directors, ex-group CEO